The Immune Response to Class I-Associated Tumor-Specific Cutaneous T-Cell Lymphoma Antigens
Open Access
- 1 September 1996
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 107 (3) , 392-397
- https://doi.org/10.1111/1523-1747.ep12363378
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.The Journal of Experimental Medicine, 1996
- Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.The Journal of Experimental Medicine, 1995
- Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.The Journal of Experimental Medicine, 1995
- Source of unique tumour antigensNature, 1994
- Expression of the target antigen for cytotoxic T lymphocytes on adult T‐cell‐leukemia cellsInternational Journal of Cancer, 1993
- Intraepidermal localization of the clone in cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1992
- Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1992
- Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complexNature, 1992
- Anti-V Region Antibodies as “Almost Clonotypic” Reagents for the Study of Cutaneous T Cell Lymphomas and LeukemiasJournal of Investigative Dermatology, 1990
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987